Clinical aspects and epidemiology of uncomplicated cystitis in women. German results of the ARESC study;Klinik und Epidemiologie der unkomplizierten Zystitis bei Frauen Deutsche Ergebnisse der ARESC-studie

Urologe - Ausgabe A

Volumn 49, Issue 2, 2010, Pages 253-261

  Wagenlehner, F M E ^a   Wagenlehner, C ^b   Savov, O ^c   Guaico, L ^d   Schito, G ^d   Naber, K G ^e  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b Agaplesion Evangelisches Krankenhaus Mittelhessen   (Germany)

^c Facharzt für Dermatologie   (Germany)

^d Mikrobiologisches Institut   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Ciprofloxacin; Cotrimoxazol; Fosfomycin; Nitrofurantoin; Uncomplicated cystitis

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; MECILLINAM; NITROFURANTOIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL FEATURE; CYSTITIS; DISEASE COURSE; DRUG ACTIVITY; ENTEROCOCCUS; FEMALE; GERMANY; HUMAN; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; PROTEUS MIRABILIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS SAPROPHYTICUS; SYMPTOM; URINALYSIS; URINE CULTURE; UROPATHOGENIC ESCHERICHIA COLI;

ADOLESCENT; ADULT; AGED; BACTERIURIA; CROSS-SECTIONAL STUDIES; CYSTITIS; DRUG RESISTANCE, BACTERIAL; FEMALE; GERMANY; HEALTH SURVEYS; HUMANS; INCIDENCE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; YOUNG ADULT;

EID: 77952675544     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-009-2145-7     Document Type: Article

References (41)

1. Clinical and Laboratory Standards Institute (2006) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7. edn. Wayne, PA, CLSI
2. Clinical and Laboratory Standards Institute (2007) Performance standards for antimicrobial susceptibility testing, 17th Informational supplement. Wayne, PA, CLSI
3. Deutsches Institut für Normung e.V. (2004) Medizinische Mikrobiologie - Empfindlichkeitsprufung von mikrobiellen Krankheitserregern gegen Chemotherapeutika -Teil 4: Bewertungsstufen fu r die minimalen Hemmkonzentrationen - MHK-Grenzwerte von antibakteriellen Wirkstoffen. Beiblatt zu DIN 58940-1. August 2005, Beuth, Berlin, DIN 58940-4 Bbl 1:2004
4. Fadda G, Nicoletti G, Schito GC, Tempera G (2005) Antimicrobial susceptibility patterns of contemporary pathogens from uncomplicated urinary tract infections isolated in a multicenter Italian survey: possible impact on guidelines. J Chemother 17:251-257 (Pubitemid 40992261)
5. Fourcroy JL, Berner B, Chiang Y-K et al (2005) Efficacy and safety of a novel once-daily extendedrelease ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women. Antimicrob Agents Chemother 49:4137-4143 (Pubitemid 41400956)
6. Foxman B (2002) Epidemiology of urinary tract infections: incidence, morbidity and economic costs. Am J Med 113(Suppl 1A):5-13
7. Goettsch WG, Janknegt R, Herings RM (2004) Increased treatment failure after 3-days' courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database. Br J Clin Pharmacol 58:184-189 (Pubitemid 39043999)
8. Gupta K, Hooton TM, Roberts PL, Stamm WE (2007) Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med 167:2207-2212 (Pubitemid 350106740)
9. Gupta K, Stamm WE (2002) Outcomes associated with trimethoprim/ sulphamethoxazole (TMP/SMX) therapy in TMP/SMX resistant communityaquired UTI. Int J Antimicrob Agents 19:554-556 (Pubitemid 34831660)
10. Henry DC Jr, Bettis RB, Riffer E et al (2002) Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women. Clin Ther 24:2088-2104 (Pubitemid 36051533)
11. Hooton TM, Scholes D, Gupta K et al (2005) Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. JAMA 293:949-955 (Pubitemid 40271126)
12. Hooton TM (2003) Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection, Int J Antimicrob Agents 22:65-72
13. Iravanl A, Klimberg I, Briefer C et al (1999) A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. J Antimicrob Chemother 43(Suppl A):67-75 (Pubitemid 29123504)
14. Iravani A, Tice AD, McCarty J et al (1995) Shortcourse ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose.The Urinary Tract Infection Study Group. Arch Intern Med 155(5):485-494
15. Kahlmeter G (2003) Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO SENS study, Int J Antimicrob Agents 22:49-52
16. Kahlmeter G (2000) The ECO-SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens - interim report. J Antimicrob Chemother 46(Suppl 1 ):15-22
17. Krieger JN, Ross SO, Simonsen JM (1993) Urinary tract infections in healthy university men. J Urol 149:1046-1048 (Pubitemid 23133767)
18. Kunin C (1997) Detection, prevention and management of UTIs, 5th edn. Lea & Febiger, Philadelphia
19. Lecomte F, Allaert FA (1997) Single-dose treatment of cystitis with fosfomycin trometanol (Monuril): analysis of 15 comparative trials on 2,048 patients. Giorn It Ost Gin 19:399-404 (Pubitemid 28037585)
20. MacLean AB (1997) Urinary tract infection in pregnancy. Br J Urol 80(Suppl 1 ):10-13
21. McCarty JM, Richard G, Huck W et al (1999) A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group. Am J Med 106(3):292-299 (Pubitemid 29153406)
22. Minassian MA, Lewis DA, Chattopadhyay D et al (1998) A comparison between single- dose fosfomycin trometanol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women, Int J Antimicrob Agents 10:39-47 (Pubitemid 28234359)
23. Naber KG, Bishop MC, Bjerklund-Johansen TE et al (2007) The management of urinary and male genital tract infections. European Association of Urology. Guidelines edition ISBN-13:978-90-70244-59-60
24. Naber KG, Koch EM (1993) Cefuroxime axetil versus ofloxacin for short-term therapy of acute uncomplicated lower urinary tract infections in women. Infection 21:34-49
25. Naber KG, Schito G, Botto H et al (2008) Surveillance Study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): Implications for empiric therapy. Eur Urol 54:1164-1178
26. Naber KG (2000) Survey on antibiotic usage in the treatment of urinary tract infections. J Antimicrob Chemother 46(Suppl 1):49-52
27. Nicolle LE, Madsen KS, Debeeck GO et al (2002) Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women. Scand J Infect Dis 34:487-492
28. Nicolle LE (2000) Pivmecilinam in the treatment of urinary tract infections. J Antimicrob Chemother 46(Suppl 1):35-39
29. Nicolle LE (2005) Urinary tract infections in diabetes. Curr Opin Infect Dis 18:49-53
30. Peterson J, Kaul S, Khashab M et al (2008) A doubleblind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. Urology 71:17-22 (Pubitemid 351173271)
31. Raz R, Chazan B, Kennes Y, Colodner R et al (2002) the Israeli Urinary Tract Infection Group. Empiric use of trimethoprim- sulfamethoxazole (TMPSMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with high prevalence of TMP-SMXresistant uropathogens. Clin Infect Dis 34:1165-1169
32. Raz R, Gennesin Y, Wasser J et al (2000) Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis 30:152-156 (Pubitemid 30067073)
33. Richard GA, De Abate CA, Ruoff GE et al (1998) A double-blind, randomised trial of the efficacy and safety of short-course, once-daily levofloxacin versus ofloxacin twice daily in uncomplicated urinary tract infection. Infect Dis Clin Pract 9:323-329
34. Rubin RH, Shapiro ED, Andriole VT et al (1992) Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infect Dis Soc Am Food Drug Adm Clin Infect Dis 15(Suppl 1 ):216-227
35. Schito GC (2003) Why fosfomycin trometanol as first line therapy for uncomplicated UTI? Int J Antimicrob Agents 22(Suppl 20)79-83
36. Spencer RC, Moseley DJ, Greensmith MJ (1994) Nitrofurantoin modified release versus trimethoprim or cotrimoxazole in the treatment of uncomplicated urinary tract infection in general practice. J Antimicrob Chemother 33(Suppl A):121-129
37. Stamm WE, Counts GW, Running KR et al (1982) Diagnosis of coliform infection in acutely dysuric women. N Engl J Med 307:463-468
38. Stamm WE (1997) Urinary tract infections in young men. In: Bergan T (ed) Urinary tract infections. Karger, Basel, pp 46-47
39. Stein GE (1999) Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. Clin Ther 21:1824-1872
40. Vogel F, Naber KG, Adam D et al (2005) Aktuelle Bewertung der Fluorchlnolone. Arzneimitteltherapie 23:130-136
41. Warren JW, Abrutyn E, Hebel JR et al (1999) Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 29:745-758 (Pubitemid 30256361)